• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Policy, Organisation and…
  • Quality of Life

Capturing the Broader Value of Antibiotics

STEDI Roadmap
Read more
  • Health Technology Assessment…
  • Economics of Innovation
  • Innovation

Innovation for Health System Efficiency and Improvement

Report picture
Read more
  • Drug Development/R&D
  • Value, Affordability, and…
  • Value based pricing

Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

6
Read more
  • Antimicrobial Resistance (AMR)
  • Value, Affordability, and…

Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Proposal for a Novel Antimicrobial  Subscription
Read more
  • Health Care Systems
  • Policy, Organisation and…
  • Economic Evaluation

Reimagining Prevention for a Healthier, More Prosperous Society

Prev web
Read more
  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 7th May 2015

OHE at ISPOR Philadelphia Part 1: MCDA, Utility Functions and Big Data

This post is the first of a two part summary of OHE’s scheduled activity at ISPOR Philadelphia 2015. ISPOR’s 20th Annual International Meeting is scheduled for 16-20 May 2015 in Philadelphia. OHE’s Adrian Towse is ISPOR president and will be…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

This post is the first of a two part summary of OHE’s scheduled activity at ISPOR Philadelphia 2015.

ISPOR’s 20th Annual International Meeting is scheduled for 16-20 May 2015 in Philadelphia. OHE’s Adrian Towse is ISPOR president and will be participating in several sessions. Other OHE team members will also be attending and presenting important research. This post is the first of a two part summary of OHE’s scheduled activity at ISPOR. 

Directly eliciting personal utility functions: A new way to value health-related quality of life

Koonal Shah (presenting author, OHE), Nancy Devlin (OHE), Brendan Mulhern (University of Technology Sydney) and Ben van Hout (University of Sheffield)

The end product of EQ-5D valuation studies is an algorithm describing, on average, the utility decrements associated with each dimension and level of problems within the EQ-5D descriptive system. Standard methods for eliciting health state preference data (e.g. time trade-off, discrete choice experiment) aim to ‘uncover’ these preferences by asking survey respondents to evaluate a sub-set of health states, and then using their responses to infer the relative importance of the specific dimensions and levels to them. An alternative (and novel) approach is to directly ask respondents about their own personal utility functions. This poster will describe the development of an innovative set of questions designed to directly elicit personal utility functions from members of the general public. The approach is informed by swing weighting techniques in the multi-criteria decision analysis literature and by existing direct valuation methods.

Monday 18 May, Poster presentations session I
Poster display hours: 8:30 AM – 2:15 PM
Author discussion: 1:15 PM – 2:15 PM
 
The ISPOR MCDA task force: How best to use it in health care decision making
 
Discussion leaders: Maarten  IJzerman (University of Twente), Nancy Devlin (OHE), Praveen Thokala (University of Sheffield), Kevin Marsh (Evidera).
 
The purpose of this workshop is for the ISPOR MCDA Emerging Good Practices Task Force to present preliminary recommendations for using MCDA. Attendees will hear key lessons to support the application of MCDA across a range of health care decisions, and will be invited comment on the preliminary recommendations.
 
Tuesday 19 May, Workshops – session III
5:00 PM – 6:00 PM
 
Big data, big systems, and better evidence: what progress?
 
Moderator: Adrian Towse (OHE). Speakers: Ari Caroline (Memorial Sloan Kettering Cancer Center), Jamie C. Morris (IBM Watson Group), Paul Wallace (Optum Labs).
 
This plenary session will explore the potential approaches to using big data in clinical decision making. Challenges, new analytical approaches, and the impact these will have on patients will be discussed.
 
Wednesday 20 May, third plenary session

9:45 AM – 11:00 AM

 

  • EQ-5D and PROMs
  • Value, Affordability, and…
  • Presentations

Related News

  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
  • News
  • March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Read more
  • News
  • January 2020

Funding Challenges in the Malaysian Health Care System

Read more
  • News
  • January 2020

OHE at HESG Winter 2020

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!